Table 1 Patients demographics of the localized cohort stratified based on CRISP3 expression
Parameter | Negative/weak (n = 137) | Moderate/high (n = 78) | p-value |
|---|---|---|---|
Age (years) (mean; range) | 64.53 (43–81) | 63.58 (47–78) | 0.280 |
Pre-PSA level (ng/ml) | 0.212 | ||
= < 10 | 43 (68%) | 28 (80%) | |
>10 | 20 (32%) | 7 (20%) | |
Gleason summary | 0.750 | ||
<7 | 43 (32%) | 25 (33%) | |
3 + 4 | 43 (32%) | 24 (31%) | |
4 + 3 | 31 (22%) | 20 (26%) | |
>7 | 19 (14%) | 8 (10%) | |
pT-stage | 0.091 | ||
pT2 | 81 (62%) | 54 (74%) | |
pT3 | 49 (38%) | 19 (26%) | |
Surgical margin | 0.285 | ||
Negative | 69 (53%) | 45 (61%) | |
Positive | 61 (47%) | 29 (39%) |